Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Jun 21, 2019 at 10:08 AM EDT

FDA Ignites Ocular Inflammation Treatment Dextenza in Most Recent Approval

Ocular Therapeutix shares jumped on Friday after the firm announced that the U.S. Food and Drug Administration (FDA) approved a…

Jon C. Ogg | Jun 19, 2019 at 2:45 PM EDT

Canadian Marijuana Use Jumps Even More Than Expected After Legalization

Marijuana trends showing higher use after cannabis legalization in Canada.

Hristina Byrnes | Jun 19, 2019 at 9:50 AM EDT

Study Shows How Pomegranates May Help Keep Us Younger

Swiss researchers have established that tannins found in pomegranates are converted in the digestive system into a compound that appears…

Chris Lange | Jun 19, 2019 at 9:23 AM EDT

Why This FDA Approval for Pneumonia Treatment Is So Huge

Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA)…

Jon C. Ogg | Jun 19, 2019 at 8:53 AM EDT

One Firm Sees Up to 45% Upside in Top Companies in Life Sciences Tools

Health care stocks still have plenty of upside in them. Agilent, Danaher, Thermo Fisher are all stocks to buy.

Jon C. Ogg | Jun 18, 2019 at 2:03 PM EDT

Two Very Speculative Biotechs With Promising Alzheimer’s Treatment Hopefuls

Analyst Yun Zhong looks at two treatments for Alzheimer Disease and other dementias that could beat the odds and be…

Chris Lange | Jun 18, 2019 at 11:57 AM EDT

Tuesday’s Top BioPharma Movers Deviating from the Market

24/7 Wall St. has picked a few of those standouts from Tuesday to highlight. We have included information about each…

Chris Lange | Jun 18, 2019 at 10:22 AM EDT

How PhaseBio Pharma Could Change the Game in Antiplatelet Therapy

PhaseBio Pharmaceuticals shares jumped on Tuesday after the firm announced preliminary results from its mid-stage trial on subjects on dual…

Chris Lange | Jun 17, 2019 at 1:05 PM EDT

How Aclaris Is On Track to Treat Baldness

Baldness is something that many men fear as they age, and understandably so. But Aclaris Therapeutics may have found an…

Hristina Byrnes | Jun 17, 2019 at 12:12 PM EDT

Can This Pill Stave Off Alzheimer’s While Lowering Blood Pressure?

A blood pressure medication widely used in Europe and Japan might have potential to slow down the progress of Alzheimer’s…

Chris Lange | Jun 17, 2019 at 11:56 AM EDT

How Much Is Pfizer Overpaying For Array Bio?

Array BioPharma shares shot up on Monday after the firm announced that it would be acquired by Pfizer in an…

Douglas A. McIntyre | Jun 17, 2019 at 9:06 AM EDT

This Form of Cancer Will Kill More People Than the Most Common Cancer in 2019

Annual deaths from cancer have dropped 27% in the last 25 years, according to the American Cancer Society (ACS). However,…

Douglas A. McIntyre | Jun 15, 2019 at 7:11 AM EDT

It’s 119 Degrees In This City Now, And It’s Not Getting Better

Heat waves swung through Phoenix the week and pushed temperatures as high as 110 degrees Fahrenheit. In New Delhi, India,…

Jon C. Ogg | Jun 14, 2019 at 11:45 AM EDT

High Hopes and Expectations for Merck’s First Investor Day in Years

Merck is set to host its Investor Day on June 20. Investors will have a high bar of expectations because…

Chris Lange | Jun 14, 2019 at 9:35 AM EDT

Why ArQule’s Early-Stage Hematology Study Could Be Transformational

ArQule shares jumped early on Friday after the firm announced preliminary results from an early-stage study in patients with relapsed…

1 … 95 96 97 98 99 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

FDA Ignites Ocular Inflammation Treatment Dextenza in Most Recent Approval

Canadian Marijuana Use Jumps Even More Than Expected After Legalization

Study Shows How Pomegranates May Help Keep Us Younger

Why This FDA Approval for Pneumonia Treatment Is So Huge

One Firm Sees Up to 45% Upside in Top Companies in Life Sciences Tools

Two Very Speculative Biotechs With Promising Alzheimer’s Treatment Hopefuls

Tuesday’s Top BioPharma Movers Deviating from the Market

How PhaseBio Pharma Could Change the Game in Antiplatelet Therapy

How Aclaris Is On Track to Treat Baldness

Can This Pill Stave Off Alzheimer’s While Lowering Blood Pressure?

How Much Is Pfizer Overpaying For Array Bio?

This Form of Cancer Will Kill More People Than the Most Common Cancer in 2019

It’s 119 Degrees In This City Now, And It’s Not Getting Better

High Hopes and Expectations for Merck’s First Investor Day in Years

Why ArQule’s Early-Stage Hematology Study Could Be Transformational

Nvidia and Micron Have Driven the S&P 500’s 2026 Rally to Record Highs. History Says It’s Not Over

A Retired Couple Can Pull About $47,500 From Their IRAs This Year and Pay $0 Federal Tax. Most Leave the Free Space Unused.

Palantir vs. Salesforce: Two Visions of Enterprise AI, One Clear Winner

A Retired Couple Can Pull About $47,500 From Their IRAs This Year and Pay $0 Federal Tax. Most Leave the Free Space Unused.

Social Security Said He Owed $18,000. Before Draining His Savings, He Had Three Cards to Play.

Nvidia and Micron Have Driven the S&P 500’s 2026 Rally to Record Highs. History Says It’s Not Over

A Retired Couple Can Pull About $47,500 From Their IRAs This Year and Pay $0 Federal Tax. Most Leave the Free Space Unused.

Health and Healthcare Articles

All Health and Healthcare Articles

FDA Ignites Ocular Inflammation Treatment Dextenza in Most Recent Approval

Canadian Marijuana Use Jumps Even More Than Expected After Legalization

Study Shows How Pomegranates May Help Keep Us Younger

Why This FDA Approval for Pneumonia Treatment Is So Huge

One Firm Sees Up to 45% Upside in Top Companies in Life Sciences Tools

Two Very Speculative Biotechs With Promising Alzheimer’s Treatment Hopefuls

Tuesday’s Top BioPharma Movers Deviating from the Market

How PhaseBio Pharma Could Change the Game in Antiplatelet Therapy

How Aclaris Is On Track to Treat Baldness

Can This Pill Stave Off Alzheimer’s While Lowering Blood Pressure?

How Much Is Pfizer Overpaying For Array Bio?

This Form of Cancer Will Kill More People Than the Most Common Cancer in 2019

It’s 119 Degrees In This City Now, And It’s Not Getting Better

High Hopes and Expectations for Merck’s First Investor Day in Years

Why ArQule’s Early-Stage Hematology Study Could Be Transformational

Nvidia and Micron Have Driven the S&P 500’s 2026 Rally to Record Highs. History Says It’s Not Over

A Retired Couple Can Pull About $47,500 From Their IRAs This Year and Pay $0 Federal Tax. Most Leave the Free Space Unused.

Palantir vs. Salesforce: Two Visions of Enterprise AI, One Clear Winner

Featured Reads

A Retired Couple Can Pull About $47,500 From Their IRAs This Year and Pay $0 Federal Tax. Most Leave the Free Space Unused.

Social Security Said He Owed $18,000. Before Draining His Savings, He Had Three Cards to Play.